UB Paderborn / Katalog / Suche / in CDI

1 – 8 von 8

Sortiert nach

Exploring the relationship between Overall Survival (OS), Progression Free Survival (PFS) and Objective Response Rate (ORR) in patients with advanced melanoma

Cancer treatment and research communications, 2021, Vol.26, p.100272-100272, Article 100272

2021

Volltextzugriff (PDF)

Clustering and prediction of disease progression trajectories in Huntington's disease: An analysis of Enroll-HD data using a machine learning approach

Frontiers in neurology, 2023-01, Vol.13, p.1034269-1034269

2023

Volltextzugriff (PDF)

The Impact of Omalizumab Therapy on Sleep in Patients With Nasal Polyps

Journal of allergy and clinical immunology, 2021-02, Vol.147 (2), p.AB244-AB244

2021

Volltextzugriff (PDF)

Omalizumab improves sleep and health status for patients with chronic rhinosinusitis with nasal polyps: An analysis of randomized clinical trials

International forum of allergy & rhinology, 2024-07, Vol.14 (7), p.1163-1172

2024

Volltextzugriff (PDF)

Age of asthma onset does not impact the response to omalizumab

Chronic respiratory disease, 2023-01, Vol.20, p.14799731231159673-14799731231159673

2023

Volltextzugriff (PDF)

Outcomes of Influenza with Treatment in Patients with Diabetes: Subgroup Analysis of the Phase 3 CAPSTONE-2 Trial

Metabolism, clinical and experimental, 2021-03, Vol.116, p.154624, Article 154624

2021

Volltextzugriff (PDF)

Safety and efficacy of nazartinib (EGF816) in adults with EGFR-mutant non-small-cell lung carcinoma: a multicentre, open-label, phase 1 study

The lancet respiratory medicine, 2020-06, Vol.8 (6), p.561-572

2020

Volltextzugriff (PDF)

Preliminary Phase II results of a multicenter, open-label study of nazartinib (EGF816) in adult patients with treatment-naïve EGFR -mutant non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.9094-9094

2018

Volltextzugriff (PDF)

1 – 8 von 8

Suche als RSS-Feed

Aktive Filter

ThemaAllergy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(8)
Mit Volltextzugriff
(8)

Publikationsform

Artikel
(8)

Sprache

Englisch
(8)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(4)
Science & Technology
(4)
Clinical Trials
(3)
Immunoglobulin E
(3)
Monoclonal Antibodies
(3)
Humans
(2)
Polyps
(2)
Respiratory System
(2)
Sleep
(2)
Advanced Melanoma
(1)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(1)
Asthma
(1)
Asthma - Drug Therapy
(1)
Chronic Illnesses
(1)
Chronic Rhinosinusitis
(1)
Clinical Neurology
(1)
Clustering
(1)
Critical Care Medicine
(1)
Exacerbations
(1)
General & Internal Medicine
(1)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Exploring the relationship between Overall Survival (OS), Progression Free Survival (PFS) and Objective Response Rate (ORR) in patients with advanced melanoma

Clustering and prediction of disease progression trajectories in Huntington's disease: An analysis of Enroll-HD data using a machine learning approach

The Impact of Omalizumab Therapy on Sleep in Patients With Nasal Polyps

Omalizumab improves sleep and health status for patients with chronic rhinosinusitis with nasal polyps: An analysis of randomized clinical trials

Age of asthma onset does not impact the response to omalizumab

Outcomes of Influenza with Treatment in Patients with Diabetes: Subgroup Analysis of the Phase 3 CAPSTONE-2 Trial

Safety and efficacy of nazartinib (EGF816) in adults with EGFR-mutant non-small-cell lung carcinoma: a multicentre, open-label, phase 1 study

Preliminary Phase II results of a multicenter, open-label study of nazartinib (EGF816) in adult patients with treatment-naïve EGFR -mutant non-small cell lung cancer (NSCLC)

Aktive Filter

Suchergebnisse filtern